| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |